The potential of glucose management indicator for the estimation of glucose disposal rate in people with type 1 diabetes

被引:0
作者
Cutruzzola, Antonio [1 ]
Parise, Martina [2 ]
Scavelli, Faustina Barbara [3 ]
Fiorentino, Raffaella [3 ]
Luca, Stefania [2 ]
Di Molfetta, Sergio [4 ]
Gnasso, Agostino [1 ]
Irace, Concetta [2 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Clin & Expt Med, I-88100 Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy
[3] Univ Hosp, Sect Metab Dis, I-88100 Catanzaro, Italy
[4] Univ Bari Aldo Moro, Dept Precis & Regenerat Med & Ionian Area, Sect Internal Med Endocrinol Androl & Metab Dis, Piazza Giulio Cesare N 11, I-70124 Bari, Italy
关键词
Type; 1; diabetes; Insulin resistance; Glucose disposal rate; Continuous glucose monitoring; Glucose management indicator; Diabetes complications; DAILY INSULIN INJECTIONS; METABOLIC SYNDROME; WEIGHT-GAIN; RESISTANCE; ATHEROSCLEROSIS; COMPLICATIONS; MULTICENTER; POPULATION; DISEASE; ADULTS;
D O I
10.1016/j.numecd.2024.06.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Insulin resistance is a growing feature in type 1 diabetes (T1D). It can be quantified by calculating the estimated glucose disposal rate (eGDR) with the Epstein's formula, which includes laboratory-measured glycated hemoglobin (HbA1c). We aimed the current research to assess the agreement between the conventional eGDR formula and an alternative one (eGDR-GMI) incorporating the glucose management indicator (GMI) derived from continuous glucose monitoring (CGM). We also explored the relationship between eGDR-GMI, cardiovascular risk factors, and the prevalence of diabetes-related complications.<br /> Methods and results: We designed a cross-sectional study that included adults with T1D. eGDRGMI and eGDR (mg/kg/min) were calculated using GMI or HbA1c, waist circumference, and hypertensive state. Clinical data were collected from electronic medical records.<br /> The analyses encompassed 158 participants with a mean age of 39 f 13 years. The BlandAltman analysis showed a good agreement between eGDR-GMI and eGDR. When we divided participants in eGDR-GMI tertiles we found a higher prevalence of diabetes-related complications and a less favorable metabolic profile in the lowest eGDR-GMI tertile. The relative risk of retinopathy, nephropathy, and neuropathy significantly increased by approximately 1 unit with each decrease in eGDR-GMI, regardless of age, sex, disease duration, lipids, and smoking habit.<br /> Conclusions: eGDR-GMI represents a valid and robust alternative to the eGDR to assess insulin resistance in T1D. Low eGDR-GMI is associated with diabetes complications and a less favorable metabolic profile. Incorporating the eGDR-GMI into clinical practice can enhance the characterization of T1D people and allow for a more personalized treatment approach. (c) 2024 The Author(s). Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:2344 / 2352
页数:9
相关论文
共 42 条
  • [1] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
    Battelino, Tadej
    Danne, Thomas
    Bergenstal, Richard M.
    Amiel, Stephanie A.
    Beck, Roy
    Biester, Torben
    Bosi, Emanuele
    Buckingham, Bruce A.
    Cefalu, William T.
    Close, Kelly L.
    Cobelli, Claudio
    Dassau, Eyal
    DeVries, J. Hans
    Donaghue, Kim C.
    Dovc, Klemen
    Doyle, Francis J.
    Garg, Satish
    Grunberger, George
    Heller, Simon
    Heinemann, Lutz
    Hirsch, Irl B.
    Hovorka, Roman
    Jia, Weiping
    Kordonouri, Olga
    Kovatchev, Boris
    Kowalski, Aaron
    Laffel, Lori
    Levine, Brian
    Mayorov, Alexander
    Mathieu, Chantal
    Murphy, Helen R.
    Nimri, Revital
    Norgaard, Kirsten
    Parkin, Christopher G.
    Renard, Eric
    Rodbard, David
    Saboo, Banshi
    Schatz, Desmond
    Stoner, Keaton
    Urakami, Tatsuiko
    Weinzimer, Stuart A.
    Phillip, Moshe
    [J]. DIABETES CARE, 2019, 42 (08) : 1593 - 1603
  • [2] Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial
    Beck, Roy W.
    Riddlesworth, Tonya D.
    Ruedy, Katrina J.
    Kollman, Craig
    Ahmann, Andrew J.
    Bergenstal, Richard M.
    Bhargava, Anuj
    Bode, Bruce W.
    Haller, Stacie
    Kruger, Davida F.
    McGill, Janet B.
    Polonsky, William
    Price, David
    Toschi, Elena
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (09) : 700 - 708
  • [3] Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
    Bergenstal, Richard M.
    Beck, Roy W.
    Close, Kelly L.
    Grunberger, George
    Sacks, David B.
    Kowalski, Aaron
    Brown, Adam S.
    Heinemann, Lutz
    Aleppo, Grazia
    Ryan, Donna B.
    Riddlesworth, Tonya D.
    Cefalu, William T.
    [J]. DIABETES CARE, 2018, 41 (11) : 2275 - 2280
  • [4] Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
    Castellana, Marco
    Parisi, Claudia
    Di Molfetta, Sergio
    Di Gioia, Ludovico
    Natalicchio, Annalisa
    Perrini, Sebastio
    Cignarelli, Angelo
    Laviola, Luigi
    Giorgino, Francesco
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [5] Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?
    Cleland, S. J.
    Fisher, B. M.
    Colhoun, H. M.
    Sattar, N.
    Petrie, J. R.
    [J]. DIABETOLOGIA, 2013, 56 (07) : 1462 - 1470
  • [6] Insulin Resistance and CGM-Derived Parameters in People With Type 1 Diabetes: Are They Associated?
    Clinck, Isabel
    Mertens, Jonathan
    Wouters, Kristien
    Dirinck, Eveline
    De Block, Christophe
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (11) : e2131 - e2140
  • [7] Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes
    de Vries, Marieke
    Westerink, Jan
    El-Morabit, Fatima
    Kaasjager, H. A. H.
    de Valk, Harold W.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [8] A guide for the use of LibreView digital diabetes platform in clinical practice: Expert paper of the Italian Working Group on Diabetes and Technology
    Di Molfetta, Sergio
    Rossi, Antonio
    Assaloni, Roberta
    Cherubini, Valentino
    Consoli, Agostino
    Di Bartolo, Paolo
    Guardasole, Vincenzo
    Laurenzi, Andrea
    Lombardo, Fortunato
    Maffeis, Claudio
    Scaramuzza, Andrea
    Irace, Concetta
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 187
  • [9] Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis
    Donga, Esther
    Dekkers, Olaf M.
    Corssmit, Eleonora P. M.
    Romijn, Johannes A.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 173 (01) : 101 - 109
  • [10] Use of the Estimated Glucose Disposal Rate as a Measure of Insulin Resistance in an Urban Multiethnic Population With Type 1 Diabetes
    Epstein, Eric J.
    Osman, Jamie L.
    Cohen, Hillel W.
    Rajpathak, Swapnil N.
    Lewis, Oksana
    Crandall, Jill P.
    [J]. DIABETES CARE, 2013, 36 (08) : 2280 - 2285